INHIBITORS OF CYTOMEGALOVIRUS
Compounds of Formula (I) wherein R1, R2, R3A, R3B, Y, Z1 and Z2 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection. L'invention concerne des composés de formule (I) dans laquelle R1, R2, R3A, R3B, Y, Z1 et Z2 ont la signification indiquée dans la descri...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LEBLANC, MELISSA SURPRENANT, SIMON THIBEAULT, CARL DECOR, ANNE MOREAU, BENOIT KUHN, CYRILLE HUCKE, OLIVER JOLICOEUR, ERIC GRAND-MAITRE, CHANTAL BEAULIEU, PIERRE L LACOSTE, JEAN-ERIC VILLEMURE, ELISIA RANCOURT, JEAN |
| description | Compounds of Formula (I) wherein R1, R2, R3A, R3B, Y, Z1 and Z2 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
L'invention concerne des composés de formule (I) dans laquelle R1, R2, R3A, R3B, Y, Z1 et Z2 ont la signification indiquée dans la description, qui sont utiles pour le traitement d'une maladie et/ou d'une infection à cytomégalovirus. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2014070976A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2014070976A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2014070976A13</originalsourceid><addsrcrecordid>eNrjZJD19PPwdPIM8Q8KVvB3U3CODPH3dXV39PEP8wwKDeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhiYG5gaW5maOhsbEqQIAN5kiWQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBITORS OF CYTOMEGALOVIRUS</title><source>esp@cenet</source><creator>LEBLANC, MELISSA ; SURPRENANT, SIMON ; THIBEAULT, CARL ; DECOR, ANNE ; MOREAU, BENOIT ; KUHN, CYRILLE ; HUCKE, OLIVER ; JOLICOEUR, ERIC ; GRAND-MAITRE, CHANTAL ; BEAULIEU, PIERRE L ; LACOSTE, JEAN-ERIC ; VILLEMURE, ELISIA ; RANCOURT, JEAN</creator><creatorcontrib>LEBLANC, MELISSA ; SURPRENANT, SIMON ; THIBEAULT, CARL ; DECOR, ANNE ; MOREAU, BENOIT ; KUHN, CYRILLE ; HUCKE, OLIVER ; JOLICOEUR, ERIC ; GRAND-MAITRE, CHANTAL ; BEAULIEU, PIERRE L ; LACOSTE, JEAN-ERIC ; VILLEMURE, ELISIA ; RANCOURT, JEAN</creatorcontrib><description>Compounds of Formula (I) wherein R1, R2, R3A, R3B, Y, Z1 and Z2 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
L'invention concerne des composés de formule (I) dans laquelle R1, R2, R3A, R3B, Y, Z1 et Z2 ont la signification indiquée dans la description, qui sont utiles pour le traitement d'une maladie et/ou d'une infection à cytomégalovirus.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140508&DB=EPODOC&CC=WO&NR=2014070976A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140508&DB=EPODOC&CC=WO&NR=2014070976A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LEBLANC, MELISSA</creatorcontrib><creatorcontrib>SURPRENANT, SIMON</creatorcontrib><creatorcontrib>THIBEAULT, CARL</creatorcontrib><creatorcontrib>DECOR, ANNE</creatorcontrib><creatorcontrib>MOREAU, BENOIT</creatorcontrib><creatorcontrib>KUHN, CYRILLE</creatorcontrib><creatorcontrib>HUCKE, OLIVER</creatorcontrib><creatorcontrib>JOLICOEUR, ERIC</creatorcontrib><creatorcontrib>GRAND-MAITRE, CHANTAL</creatorcontrib><creatorcontrib>BEAULIEU, PIERRE L</creatorcontrib><creatorcontrib>LACOSTE, JEAN-ERIC</creatorcontrib><creatorcontrib>VILLEMURE, ELISIA</creatorcontrib><creatorcontrib>RANCOURT, JEAN</creatorcontrib><title>INHIBITORS OF CYTOMEGALOVIRUS</title><description>Compounds of Formula (I) wherein R1, R2, R3A, R3B, Y, Z1 and Z2 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
L'invention concerne des composés de formule (I) dans laquelle R1, R2, R3A, R3B, Y, Z1 et Z2 ont la signification indiquée dans la description, qui sont utiles pour le traitement d'une maladie et/ou d'une infection à cytomégalovirus.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD19PPwdPIM8Q8KVvB3U3CODPH3dXV39PEP8wwKDeZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGhiYG5gaW5maOhsbEqQIAN5kiWQ</recordid><startdate>20140508</startdate><enddate>20140508</enddate><creator>LEBLANC, MELISSA</creator><creator>SURPRENANT, SIMON</creator><creator>THIBEAULT, CARL</creator><creator>DECOR, ANNE</creator><creator>MOREAU, BENOIT</creator><creator>KUHN, CYRILLE</creator><creator>HUCKE, OLIVER</creator><creator>JOLICOEUR, ERIC</creator><creator>GRAND-MAITRE, CHANTAL</creator><creator>BEAULIEU, PIERRE L</creator><creator>LACOSTE, JEAN-ERIC</creator><creator>VILLEMURE, ELISIA</creator><creator>RANCOURT, JEAN</creator><scope>EVB</scope></search><sort><creationdate>20140508</creationdate><title>INHIBITORS OF CYTOMEGALOVIRUS</title><author>LEBLANC, MELISSA ; SURPRENANT, SIMON ; THIBEAULT, CARL ; DECOR, ANNE ; MOREAU, BENOIT ; KUHN, CYRILLE ; HUCKE, OLIVER ; JOLICOEUR, ERIC ; GRAND-MAITRE, CHANTAL ; BEAULIEU, PIERRE L ; LACOSTE, JEAN-ERIC ; VILLEMURE, ELISIA ; RANCOURT, JEAN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2014070976A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LEBLANC, MELISSA</creatorcontrib><creatorcontrib>SURPRENANT, SIMON</creatorcontrib><creatorcontrib>THIBEAULT, CARL</creatorcontrib><creatorcontrib>DECOR, ANNE</creatorcontrib><creatorcontrib>MOREAU, BENOIT</creatorcontrib><creatorcontrib>KUHN, CYRILLE</creatorcontrib><creatorcontrib>HUCKE, OLIVER</creatorcontrib><creatorcontrib>JOLICOEUR, ERIC</creatorcontrib><creatorcontrib>GRAND-MAITRE, CHANTAL</creatorcontrib><creatorcontrib>BEAULIEU, PIERRE L</creatorcontrib><creatorcontrib>LACOSTE, JEAN-ERIC</creatorcontrib><creatorcontrib>VILLEMURE, ELISIA</creatorcontrib><creatorcontrib>RANCOURT, JEAN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LEBLANC, MELISSA</au><au>SURPRENANT, SIMON</au><au>THIBEAULT, CARL</au><au>DECOR, ANNE</au><au>MOREAU, BENOIT</au><au>KUHN, CYRILLE</au><au>HUCKE, OLIVER</au><au>JOLICOEUR, ERIC</au><au>GRAND-MAITRE, CHANTAL</au><au>BEAULIEU, PIERRE L</au><au>LACOSTE, JEAN-ERIC</au><au>VILLEMURE, ELISIA</au><au>RANCOURT, JEAN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBITORS OF CYTOMEGALOVIRUS</title><date>2014-05-08</date><risdate>2014</risdate><abstract>Compounds of Formula (I) wherein R1, R2, R3A, R3B, Y, Z1 and Z2 are defined herein, are useful for the treatment of cytomegalovirus disease and/or infection.
L'invention concerne des composés de formule (I) dans laquelle R1, R2, R3A, R3B, Y, Z1 et Z2 ont la signification indiquée dans la description, qui sont utiles pour le traitement d'une maladie et/ou d'une infection à cytomégalovirus.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2014070976A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | INHIBITORS OF CYTOMEGALOVIRUS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T21%3A12%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LEBLANC,%20MELISSA&rft.date=2014-05-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2014070976A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |